Complete TRVI Stock Valuation Analysis
Comprehensive intrinsic value analysis using 1 different methodologies
TRVI Peer Valuation Analysis
Relative valuation based on comparable company trading multiples
Peer Valuation Analysis
Fair Value Range Analysis
Based on median multiples from 9 peer companies in Healthcare
P/E Ratio
$-25.40
-556.4%
Peer Median: 63.1x
EV/EBITDA
$0.00
-100.0%
Peer Median: 46.0x
P/S Ratio
$0.00
-100.0%
Peer Median: 7.9x
Interpretation: Each multiple provides a different perspective on fair value. Consider which multiple is most relevant for TRVI's business model and current situation.
Multiple Comparison
| Multiple | TRVI Current | Peer Median | Peer Average | Premium/Discount | Assessment |
|---|---|---|---|---|---|
| P/E Ratio | -13.8x | 63.1x | 63.1x | -121.9% | Undervalued |
| EV/EBITDA | Infinityx | 46.0x | 46.0x | Infinity% | Overvalued |
| P/S Ratio | Infinityx | 7.9x | 7.1x | Infinity% | Overvalued |
Peer Companies
Click any company to view their valuation
| Company | Market Cap | P/E Ratio | EV/EBITDA | P/S Ratio |
|---|---|---|---|---|
| $1.22B | 0.0x | 0.0x | 0.0x | |
| $0.76B | 0.0x | 0.0x | 3.4x | |
| $0.68B | 0.0x | 0.0x | 61.6x | |
| $0.59B | 0.0x | 0.0x | 2.2x | |
| $0.66B | 0.0x | 0.0x | 0.0x | |
| $0.50B | 0.0x | 0.0x | 0.0x | |
| $0.38B | 0.0x | 0.0x | 7.9x | |
| $0.54B | 0.0x | 0.0x | 216.4x | |
| $737.42B | 63.1x | 46.0x | 15.0x |